Categories AlphaGraphs, Earnings, Health Care

Key metrics from Biogen’s (BIIB) Q4 2024 earnings results

Biogen Inc. (NASDAQ: BIIB) reported its fourth quarter 2024 earnings results today.

Total revenue increased 3% year-over-year to $2.5 billion.  

Net income attributable to Biogen Inc. was $266.8 million, or $1.83 per share, compared to $249.7 million, or $1.71 per share, last year. Adjusted EPS grew 17% YoY to $3.44.  

For full-year 2025, the company expects total revenue to decline by a mid-single digit percentage at constant currency versus full-year 2024.  Adjusted EPS is expected to be $15.25-16.25.

Prior performance

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Docusign (DOCU) Earnings: 4Q25 Key Numbers

Docusign, Inc. (NASDAQ: DOCU) reported total revenue of $776.3 million for the fourth quarter of 2025, up 9% year-over-year. Net income was $83.5 million, or $0.39 per share, compared to

DG Q4 Call Highlights: Consumer Shifts, Inventory Wins, and Rural Delivery Boom!

Dollar General Corp., a retailer that operates discount stores, in its Q4 earnings call discussed Dollar General's financial strategy to reach 6-7% operating margins by 2028 through shrink reduction, inventory

ULTA Earnings: Highlights of Ulta Beauty’s Q4 2024 results

Ulta Beauty, Inc. (NASDAQ: ULTA), a leading retailer of cosmetics and personal care products, on Thursday reported a decrease in net sales for the fourth quarter of 2024. Fourth-quarter net

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close